Drug Testing - Term Contract

The Louisiana State University Board of Supervisors has issued an Invitation to Bid (ITB) for a comprehensive Drug Testing Term Contract (Solicitation RFQ-0000002510) targeting LSU Athletics. The procurement seeks a single supplier capable of providing extensive drug testing services across 13 distinct testing categories, including synthetic cathinones, DMAA, alcohol detection, anabolic steroids, synthetic marijuana, drugs of abuse, barbiturates, Ritalin, oral fluid testing, and novel psychoactive substance testing. Specific requirements include forensic collection procedures, comprehensive testing capabilities, and strict performance standards with turnaround times ranging from 24-72 hours for negative results and up to 7 days for positive confirmations. The contract will run from July 1, 2025 to June 30, 2026, with options to renew for two additional 12-month periods. Bidders must submit electronic proposals by May 22, 2025 at 11:00 AM CT, with a subsequent Zoom bid opening. Critical evaluation criteria include the vendor's ability to perform all tests without subcontracting, provide secure internet result reporting, implement computer management software, and offer specimen validity reporting and on-site collection assistance.

The solicitation does not explicitly outline specific set-aside designations or restrictions for disadvantaged enterprises. The contract is structured as an "all-or-none" award, meaning the entire testing portfolio must be fulfilled by a single vendor. While specific budget ranges are not detailed, the testing volumes indicate substantial potential contract value, with individual test categories ranging from 30 to 2,000 tests. LSU's membership in the National Association of Educational Procurement (NAEP) and the E&I Cooperative Purchasing Service suggests potential cooperative purchasing opportunities that could expand the contract's reach. The comprehensive nature of the testing requirements indicates a preference for vendors with extensive laboratory capabilities, forensic expertise, and robust quality control mechanisms. Potential bidders should demonstrate sophisticated testing technologies, comprehensive substance screening capabilities, and the ability to handle complex athletic drug testing protocols with high levels of accuracy and confidentiality.